Description
Summary Abstract
Bromantane (developmental code N-(4-bromophenyl)adamantan-2-amine; trade name Ladasten) is a unique atypical psychostimulant and anxiolytic synthetic derivative of the adamantane class. Developed to enhance endurance and physiological resilience under extreme environments, the compound acts as an actoprotector. Unlike classic psychostimulants, it facilitates sustained physical and cognitive performance without inducing marked hyperlocomotion, severe withdrawal profiles, or significant cardiovascular depletion.
Clinical Indications
In literature and foreign clinical contexts, Bromantane has been investigated for:
- Asthenic Syndromes: Treatment of psychogenic and post-infectious fatigue states.
- Cognitive Optimization: Amelioration of neurasthenic conditions and performance deficits under heat stress.
- Anxiolysis: Stabilization of emotional states accompanied by psycho-vegetative symptoms without excessive sedation.
Contraindications
- Pregnancy & Lactation: Lacks sufficient safety profiling in developmental toxicity models.
- Hypersensitivity: Known sensitivity to adamantane derivatives or brominated compounds.
- Athletic Competition: Explicitly prohibited by the World Anti-Doping Agency (WADA) under class S6 (Stimulants).
Mechanism of Action (MOA)
The pharmacodynamics of Bromantane rely on a multifaceted, non-exhaustive cascade targeting neurotransmitter synthesis and reuptake inhibition:
Dopaminergic Up-regulation
Enhances transcription of the Tyrosine Hydroxylase (TH) and Aromatic L-Amino Acid Decarboxylase (AAAD) genes, accelerating de novo dopamine biosynthesis without depleting presynaptic vesicular pools.
Monoamine Reuptake Inhibition
Exhibits low-affinity, steady-state inhibition of both the dopamine transporter (DAT) and serotonin transporter (SERT), raising extracellular concentrations of neurotransmitters selectively within synaptic junctions.
Key Features & Specifications
Engineered to meet exact chemical research guidelines and mammalian model testing criteria:
Chemical Analysis
| Property | Specification Reference Data |
|---|---|
| IUPAC Name | N-(4-bromophenyl)adamantan-2-amine |
| CAS Number | 87913-26-6 |
| Molecular Formula | C16H20BrN |
| Molecular Weight | 306.24 g/mol |
| PubChem CID | 4660557 |
| Form / Variation | 25 mg Capsule (C-046) / 50 mg/mL Oral Solution (L-025) |
Storage, Safety, and Handling
Storage Protocol
Store ambient at controlled room temperature (15°C–25°C). Keep tightly sealed within original container, strictly protected from excessive ambient moisture and direct ultraviolet light exposure.
Handling & Compliance
Utilize standard personal protective equipment (PPE) during chemical preparation or measurement. For laboratory research use only. Not intended for human diagnostic or therapeutic applications.